Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14733367 | 1.00 | SLC29A1 (0.59) | SLC29A1HIF1A | |
| SCHEMBL29674600 | 1.00 | SLC29A1 (0.59) | SLC29A1HIF1A | |
| SCHEMBL21539907 | 1.00 | SLC29A1 (0.59) | SLC29A1HIF1A | |
| SCHEMBL264409 | 1.00 | SLC29A1 (0.59) | SLC29A1HIF1A | |
| SCHEMBL22984010 | 1.00 | SLC29A1 (0.59) | SLC29A1HIF1A | |
| Water SCHEMBL29821265 | 0.99 | SLC29A1 (0.58) | SLC29A1HIF1A | |
| SCHEMBL23881920 | 0.92 | SLC29A1 (0.49) | SLC29A1HIF1A | |
| SCHEMBL31093228 | 0.92 | SLC29A1 (0.49) | SLC29A1 | |
| SCHEMBL9342970 | 0.92 | SLC29A1 (0.49) | SLC29A1HIF1A | |
| SCHEMBL9342988 | 0.92 | SLC29A1 (0.49) | SLC29A1HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 285 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4606903-A1 | METHOD FOR ENZYMATIC SYNTHESIS OF NUCLEOSIDE CONTAINING PROTECTING GROUP, AND COMPOSITION | Asymchem Life Science (Tianjin) Co., Ltd (CN) | 2025-08-27 | — | — | EP | claimed |
| CN-118956882-A | Aptamer containing modified base and application thereof | 焕生汇生物基因技术(北京)有限公司 | 2024-11-15 | — | — | CN | claimed |
| CN-118666926-A | Glycosyl phosphoramidite monomer, preparation method thereof and synthesis method of glycosyl oligonucleotide | 上海交通大学医学院附属仁济医院 | 2024-09-20 | — | — | CN | claimed |
| WO-2024082545-A1 | METHOD FOR ENZYMATIC SYNTHESIS OF NUCLEOSIDE CONTAINING PROTECTING GROUP, AND COMPOSITION | 凯莱英生命科学技术(天津)有限公司 | 2024-04-25 | — | — | WO | claimed |
| CN-115181147-B | Preparation method of C4 '-trifluoromethylthio modified nucleoside and C4' -trifluoromethylthio modified nucleic acid | 南开大学 | 2024-04-02 | — | — | CN | claimed |
| CN-116064703-A | Method and composition for enzymatic synthesis of nucleosides containing protecting groups | 凯莱英生命科学技术(天津)有限公司 | 2023-05-05 | — | — | CN | claimed |
| CN-115181147-A | Preparation method of C4 '-trifluoromethylthio modified nucleoside and C4' -trifluoromethylthio modified nucleic acid | 南开大学 | 2022-10-14 | — | — | CN | claimed |
| CN-114369123-A | Efficient preparation method of 5' -aminodeoxynucleoside | 山东明化新材料有限公司 | 2022-04-19 | — | — | CN | claimed |
| CN-105968016-A | Carbonic ester type photosensitive reagent and preparation method thereof as well as preparation method of 5'-photolabile dN | 石平 | 2016-09-28 | — | — | CN | claimed |
| CN-104628574-A | Carbonate photosensitive reagent, preparation method thereof and preparation method of 5' -photosensitive protection nucleoside | SHI PING | 2015-05-20 | — | — | CN | claimed |
| WO-2000075154-A2 | PROTECTED NUCLEOSIDES | ALLIEDSIGNAL INC. (US) | 2000-12-14 | — | — | WO | claimed |
| EP-0548189-B1 | A METHOD OF LINKING NUCLEOSIDES WITH A SILOXANE BRIDGE | STERLING WINTHROP INC (US) | 1994-12-28 | — | — | EP | claimed |
| EP-4748940-A2 | DE NOVO SYNTHESISED GENE LIBRARIES | Twist Bioscience Corporation (US) | 2026-05-27 | — | — | EP | disclosed |
| US-20260138111-A1 | DE NOVO SYNTHESIZED GENE LIBRARIES | Twist Bioscience Corporation (US) | 2026-05-21 | — | — | US | disclosed |
| EP-4741411-A2 | OLIGONUCLEOTIDE PRODUCTION METHOD, AND NUCLEOSIDE, NUCLEOTIDE, OR OLIGONUCLEOTIDE | AJINOMOTO CO., INC. (JP) | 2026-05-13 | — | — | EP | disclosed |
| US-12569822-B2 | De novo synthesized gene libraries | Twist Bioscience Corporation (US) | 2026-03-10 | — | — | US | disclosed |
| US-4457867-A | VIRICIDES, ANTITUMOR | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1984-07-03 | — | — | US | disclosed |
| EP-0083777-A1 | Physiologically active peptide with between 147 and 162 amino acid residues | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1983-07-20 | — | — | EP | disclosed |
| EP-0064796-A2 | Phosphorylating agent and process for the phosphorylation of organic hydroxyl compounds | UNILEVER N.V. (NL) | 1982-11-17 | — | — | EP | disclosed |
| EP-0061746-A1 | Phosphoramidite compounds and their use in producing oligonucleotides | UNIVERSITY PATENTS, INC. (US) | 1982-10-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260138111-A1 | DE NOVO SYNTHESIZED GENE LIBRARIES | POLM, DNMT3A, POLN | SLC29A1 160/4885HIF1A 4431/4885 |
| US-12569822-B2 | De novo synthesized gene libraries | POLM, NSUN2, POLL | SLC29A1 356/4885HIF1A 4426/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.